XDR tuberculosis can be cured with aggressive treatment

The Lancet

Volumn 372, Issue 9647, 2008, Pages 1363-1365

  Cox, Helen ^a,b   McDermid, Cheryl ^b  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; LEVOFLOXACIN; OFLOXACIN; TUBERCULOSTATIC AGENT;

ADD ON THERAPY; ARTICLE; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 53749106547     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61205-2     Document Type: Note

References (11)

1. WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world: report No 4 (2008). http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf (accessed July 4, 2008).
2. Nathanson E., Lambregts-van Weezenbeek C., Rich M.L., et al. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 12 (2006) 1389-1397
3. Migliori G.B., Besozzi G., Girardi E., et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J 30 (2007) 623-626
4. Singh J.A., Upshur R., and Padayatchi N. XDR-TB in South Africa: no time for denial or complacency. PLoS Med 4 (2007) e50
5. Raviglione M. XDR-TB: entering the post-antibiotic era?. Int J Tuberc Lung Dis 10 (2006) 1185-1187
6. Ruddy M., Balabanova Y., Graham C., et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 60 (2005) 130-135
7. Keshavjee S., Gelmanova I.Y., Farmer P.E., et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet (2008) 10.1016/S0140-6736(08)61204-0 published online Aug 25.
8. Gandhi N.R., Moll A., Sturm A.W., et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368 (2006) 1575-1580
9. Green Light Committee. GLC program applications, as at the end of the GLC 48th review cycle (2008). http://www.who.int/tb/challenges/mdr/greenlightcommittee/report_glc_applications_cycle_48.pdf (accessed July 4, 2008).
10. WHO, Stop TB Partnership. The global MDR-TB and XDR-TB response plan 2007-2008 (2007). http://www.stoptb.org/events/world_tb_day/2008/assets/documents/news/WHO_HTM_TB_2007.387_eng.pdf (accessed July 4, 2008).
11. Feuer C. Tuberculosis research and development: a critical analysis (October, 2006). http://www.aidsinfonyc.org/tag/tbhiv/tbrandd.pd (accessed July 4, 2008).